Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Amedisys Inc before investing.

In this article, we go over a few key elements for understanding Amedisys Inc’s stock price such as:

• Amedisys Inc’s current stock price and volume
• Why Amedisys Inc’s stock price changed recently
• Upgrades and downgrades for AMED from analysts
• AMED’s stock price momentum as measured by its relative strength

About Amedisys Inc (AMED)

Before we jump into Amedisys Inc’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Amedisys, Inc. is a healthcare service company. The Company is engaged in providing care and support in the home. It delivers clinically distinct care that suits its patients' needs, whether that is home-based recovery and rehabilitation after an operation or injury or care. Its operations involve serving patients across the United States through its three operating divisions: home health, hospice, and high acuity care. Its home health segment provides compassionate healthcare to help its patients recover from surgery or illness, live with chronic diseases, and prevent avoidable hospital readmissions. The home health includes 346 care centers located in 34 states within the United States and the District of Columbia. Its hospice care is designed to provide comfort and support for those who are dealing with a terminal illness. Its high acuity care segment delivers the essential elements of inpatient hospital, skilled nursing facility care and palliative care to patients in their homes.

Want to learn more about Amedisys Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Amedisys Inc.

What Caused Amedisys Inc Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of June 28, 2024, there were 2 analysts who downgraded Amedisys Inc’s stock and 4 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Amedisys Inc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Amedisys Inc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Amedisys Inc’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Amedisys Inc (AMED) by visiting AAII Stock Evaluator.

Relative Price Strength of Amedisys Inc

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of June 28, 2024, Amedisys Inc has a weighted four-quarter relative price strength of -4.99%, which translates to a Momentum Score of 52 and is considered to be Average.

Want to learn more about how Amedisys Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Amedisys Inc Stock Price: Bottom Line

As of July 1, 2024, Amedisys Inc’s stock price is $96.68, which is up 5.32% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Amedisys Inc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.